News from NIAID-Supported Institutions

News from NIAID-Supported Institutions

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases

Visit us on the Web

Here’s your periodic update on News from NIAID-Supported Institutions. The following links will take you to the institution’s press release:

Soligenix Announces Positive One-Year High-Temperature Stability Results with ThermoVax™ Vaccine Heat Stabilization Technology 
January 15, 2014—Soligenix, Inc.

Engineering Professor Co-Authors Nature Medicine Paper on HIV 
January 13, 2014—University of Delaware

Wistar to Launch Largest Randomized Trial Aiming for an HIV Cure by Diminishing Viral Reservoir Beyond Current Therapies 
January 13, 2014— The Wistar Institute

Enanta Pharmaceuticals Initiates Phase 1 Study of MRSA Infection Candidate EDP-788 
January 13, 2014—Enanta Pharmaceuticals, Inc.

MGH/Ragon Institute Study Identifies Population of Stem-Like Cells Where HIV Persists in Spite of Treatment 
January 13, 2014—Massachusetts General Hospital

Knopp Biosciences And NIH to Collaborate in Evaluating Dexpramipexole in Patients with Hypereosinophilic Syndrome 
January 8, 2014—Knopp Biosciences LLC

Scripps Florida Scientists Identify Possible Key to Drug Resistance in Crohn’s Disease
January 8, 2014—The Scripps Research Institute

On-Demand Vaccines Possible with Engineered Nanoparticles 
January 7, 2014—University of Washington

Finding About Classic Suppressor of Immunity Points Toward New Therapies for Bad Infections 
January 7, 2014—Georgia Regents University

Draper Nanotechnology Could Fight Influenza, Other Viruses 
January 6, 2014—Draper Laboratory